Cell killing by anti-HIV immunoconjugates demonstrates overlap among metabolic and transcriptional pathways of death and activation. [PDF]
Pincus SH +6 more
europepmc +1 more source
Immunomagnetic Sample Preparation Targeting Host- and Viral-Derived Antigens for HIV-1 Isolation from Limited Plasma Volumes. [PDF]
Gulati GK +3 more
europepmc +1 more source
Theranostic vNAR-Based Immunoconjugates Achieve Selective Intracellular Cisplatin Delivery in Embedded 3D HER2-Positive Breast Cancer In Vitro Model. [PDF]
Alfonseca-Ladrón de Guevara AC +5 more
europepmc +1 more source
The next click in antibody drug conjugate development. [PDF]
Gupta A, Chandarlapaty S.
europepmc +1 more source
Emerging antibody-drug conjugate (ADC) therapies: perspectives from the global patent landscape. [PDF]
Wu T, Liu B, Jin J, Zhou Y, Yuan H.
europepmc +1 more source
Selective Chemistry Enables Simultaneous ImmunoPET and Radioimmunotherapy with a Dual-Labeled Probe. [PDF]
Kao WM +8 more
europepmc +1 more source
Comparative In Vitro Evaluation of Anti-HIV Immunotoxin, Antibody-Drug Conjugate, and Radioimmunoconjugate Targeted by the Same Antibody. [PDF]
Kuhlmann AS +12 more
europepmc +1 more source
Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer. [PDF]
Auvert E +15 more
europepmc +1 more source
Preclinical characterization of 3p-C-DEPA<sub>-NCS</sub> and 3p-C-DEPA<sub>-TFP</sub>-PEG<sub>4</sub> as potential Actinium-225 bifunctional chelators using DOTA<sub>-NCS</sub> and macropa<sub>-NCS</sub> as benchmarks. [PDF]
Pougoue Ketchemen J +8 more
europepmc +1 more source

